Medtronic, Inc. is developing a new stent graft system designed to repair thoracic aortic aneurysm. It has been selected by the FDA for an early feasibility pilot program, allowing it to be evaluated at an early stage for proof of principle and safety data. The Valiant Mona LSA system is a stent graft designed to repair a descending thoracic aortic aneurysm encroaching on the left subclavian artery (LSA). It is based of the current market-leading Valiant Captivia Thoracic Stent Graft, which...
↧